(1) In a total of 100 patients with
traumatic coma who were admitted to the intensive care unit of our Department
of Neurosurgery we examined the effect of Pyritinol after intravenous
administration.
(2) Compared to patients with the same
clinico-neurological
conditions who were, however, not treated with Pyritinol, the cases treated
by the preparation did not show any significant clinical improvement. Moreover, in the
Pyritinol group mortality rate in patients with an
unfavourable prognosis sank to 35.3% (mortality rate in the comparative group:
54.2%).
(3) Untoward effects on the
clinico-neurological condition, cortical electrogenesis, vegetative functions and body fluid parameters were not
observed after administration of the preparation
- 1. Pyritinol
on the clinical course of traumatic coma
2. Effect of pyritinol
on sequelae of head injuries.
3. Pyritinol
in the treatment of rheumatoid arthritis
4. Psychopharmacological effects of Pyritinol
5. Pyritinol
as a free radical scavenger
6. Pyritinol's
effect on brain blood flow in dementia patients
7. Stimulation of neutrophil functions by Pyritinol
8. Pyritinol's
effect on senile dementia of the Alzheimer type
9. Pyritinol's
effect on advanced dementia
